1. Home
  2. FTRE vs EVV Comparison

FTRE vs EVV Comparison

Compare FTRE & EVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$19.07

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Eaton Vance Limited Duration Income Fund of Beneficial Interest

EVV

Eaton Vance Limited Duration Income Fund of Beneficial Interest

HOLD

Current Price

$9.19

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTRE
EVV
Founded
1996
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
2023
2003

Fundamental Metrics

Financial Performance
Metric
FTRE
EVV
Price
$19.07
$9.19
Analyst Decision
Buy
Analyst Count
9
0
Target Price
$14.06
N/A
AVG Volume (30 Days)
1.5M
427.6K
Earning Date
05-05-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,723,400,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.09
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.00
N/A
52 Week Low
$6.07
$8.97
52 Week High
$21.39
$10.41

Technical Indicators

Market Signals
Indicator
FTRE
EVV
Relative Strength Index (RSI) 55.93 50.08
Support Level $15.69 $9.11
Resistance Level $21.39 $9.42
Average True Range (ATR) 1.19 0.08
MACD -0.13 0.00
Stochastic Oscillator 42.54 47.76

Price Performance

Historical Comparison
FTRE
EVV

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.

About EVV Eaton Vance Limited Duration Income Fund of Beneficial Interest

Eaton Vance Ltd Duration Income Fund is a diversified closed-end management investment company. The company's investment objective is to provide a high level of current income. The Fund also seeks capital appreciation. The Fund invests predominantly in Senior Floating-Rate Loans, Debt Obligations, Equity Securities, Derivatives as well as Foreign Securities and Currencies. The Fund invests in various industries, including aerospace and defense, automotive, building and development, healthcare, and leisure, among others.

Share on Social Networks: